Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conestat alfa prophylaxis for idiopathic non-histaminergic acquired angioedema
2016-005083-34Phase 2Active
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of c1-esterase inhibitor in Idiopathic non-histaminergic acquired angioedema (InH-AAE), sponsored by University Medical Center Utrecht. Started Apr 2017; status: active.
02
Drugs
c1-esterase inhibitor
03
Conditions
Idiopathic non-histaminergic acquired angioedema (InH-AAE)
Beyond the preview
Go deeper on 2016-005083-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005083-34.